Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.
Also called NCT04968509
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 160 participants
- Registry
-
NCT04968509
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT04968509. Randomized; single masking; primary purpose treatment. Start 2024-03-22 (actual); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis
- Condition
- Aortic Stenosis
- Intervention (Drug)
- PCSK9 inhibitors and statins with or without ezetimibe
- Intervention (Drug)
- Statins with or without ezetimibe
- Lead sponsor
- Beijing Anzhen Hospital
- Collaborator
- Beijing Municipal Health Commission
Record details
- Record id
cardio:ct-nct04968509- Content hash
c4301892cf755d77d45591023e0aed0a27783c1def88e61fa798f57c445298c4